Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

OPKO Health

Biotech & Life Sciences · Miami, United States · Founded 2007 · IPO 2007 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$901M
Market cap · Apr/2026
Revenue
$607M
Latest reported FY

Global footprint

Where OPKO Health has talent and traffic

Web traffic by country
8.1K monthly visits
across markets
🇺🇸 United States86.4%
🇮🇳 India24.7%
🇮🇱 Israel8.6%
🇩🇪 Germany2.5%
🇪🇸 Spain1.2%
Top 5 markets shown

Patent intelligence

$296M patent portfolio · 85 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$296M
32.8% of market cap · comparable to top peer Galapagos ($230M)
85 active patent families
Where OPKO Health innovates Pharmaceutical drugDosage formDiseaseFluid systemMicro fluidic
Above peer median on Strategic, Market

Quality vs same-sector peers

OPKO Health on the five Patsnap quality dimensions

OPKO Health in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where OPKO Health concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across OPKO Health and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See OPKO Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.